Edotreotide
Ga-68-DOTATOC, SomaKit TOC (edotreotide) is a small molecule pharmaceutical. Edotreotide was first approved as Ga-68-DOTATOC on 2016-12-08. It has been approved in Europe to treat neuroendocrine tumors and radionuclide imaging. It is known to target somatostatin receptor type 2.
| Trade Name | SomaKit TOC |
|---|---|
| Common Name | Edotreotide |
| Indication | neuroendocrine tumors, radionuclide imaging |
| Drug Class | Peptides: inhibition of growth hormone release |
